Search

Anti-Sortilin Antibodies for Use in Therapy by Alector LLC

The European Patent Office published patent application EP3983441A1 for Alector LLC, covering anti-sortilin antibodies for therapeutic use in neurological conditions. The application was published April 15, 2026 under IPC classification C07K 16/28 (peptides, antibodies) with designations across 35 European states. Inventors include Robert Paul, Michael F. Ward, Hua Long, Shiao-Ping Lu, Omer Rizwan Siddiqui, Arnon Rosenthal, and Herve Rhinn.